| scholarly article | Q13442814 |
| P2093 | author name string | Gordon W Laurie | |
| Robert L McKown | |||
| Suganthalakshmi Balasubbu | |||
| Marianne Gallup | |||
| Nancy A McNamara | |||
| Trinka Vijmasi | |||
| Feeling Y T Chen | |||
| P2860 | cites work | The important role of T cells and receptor expression in Sjögren's syndrome | Q35535169 |
| Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjögren's syndrome | Q37050342 | ||
| Immune profile of squamous metaplasia development in autoimmune regulator-deficient dry eye. | Q37139290 | ||
| Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease. | Q37195776 | ||
| Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group | Q41730611 | ||
| Alterations in expression of mucin, tenascin-c and syndecan-1 in the conjunctiva following retinal surgery and plaque radiotherapy | Q43718947 | ||
| A link between tear instability and hyperosmolarity in dry eye. | Q46072952 | ||
| Syndecan regulates cell migration and axon guidance in C. elegans | Q46715063 | ||
| Influence of the eye-associated lymphoid tissue (EALT) on inflammatory ocular surface disease. | Q52928043 | ||
| Hyperosmolarity-Induced Cornification of Human Corneal Epithelial Cells Is Regulated by JNK MAPK | Q56775881 | ||
| The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 | ||
| Tear osmolarity in the diagnosis and management of dry eye disease | Q83395082 | ||
| Lacrimal proline rich 4 (LPRR4) protein in the tear fluid is a potential biomarker of dry eye syndrome | Q21133793 | ||
| cDNA and genomic cloning of lacritin, a novel secretion enhancing factor from the human lacrimal gland | Q24291355 | ||
| Establishment of an appropriate animal model for lacritin studies: cloning and characterization of lacritin in monkey eyes | Q24293443 | ||
| Restricted epithelial proliferation by lacritin via PKCalpha-dependent NFAT and mTOR pathways | Q24300470 | ||
| Heparanase deglycanation of syndecan-1 is required for binding of the epithelial-restricted prosecretory mitogen lacritin | Q24303785 | ||
| Lacritin and other new proteins of the lacrimal functional unit | Q24320688 | ||
| Lacritin and the tear proteome as natural replacement therapy for dry eye | Q24594010 | ||
| Tissue transglutaminase is a negative regulator of monomeric lacritin bioactivity | Q24594029 | ||
| Lacritin rescues stressed epithelia via rapid forkhead box O3 (FOXO3)-associated autophagy that restores metabolism | Q24609781 | ||
| Targeting of heparanase-modified syndecan-1 by prosecretory mitogen lacritin requires conserved core GAGAL plus heparan and chondroitin sulfate as a novel hybrid binding site that enhances selectivity | Q24631177 | ||
| Lacritin, a novel human tear glycoprotein, promotes sustained basal tearing and is well tolerated. | Q24635929 | ||
| Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases | Q28241769 | ||
| Comparative analysis of the tear protein expression in blepharitis patients using two-dimensional electrophoresis | Q28256113 | ||
| Mass spectrometry-based proteomic analyses in contact lens-related dry eye | Q28259300 | ||
| Lacritin-induced secretion of tear proteins from cultured monkey lacrimal acinar cells | Q28287063 | ||
| Tear lacritin levels by age, sex, and time of day in healthy adults | Q30422186 | ||
| Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren's syndrome | Q34086947 | ||
| American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort | Q34260251 | ||
| Dry eye as a mucosal autoimmune disease | Q34647761 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Lacritin | Q1759126 |
| eye disease | Q3041498 | ||
| tear secretion | Q12153824 | ||
| P304 | page(s) | 5401-5409 | |
| P577 | publication date | 2014-07-17 | |
| P1433 | published in | Investigative Ophthalmology Visual Science | Q6060707 |
| P1476 | title | Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease | |
| P478 | volume | 55 |
| Q28115093 | A thermo-responsive protein treatment for dry eyes |
| Q92442286 | Advances in dry eye disease treatment |
| Q41677137 | Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjögren's syndrome |
| Q38875664 | Development of Causative Treatment Strategies for Lacrimal Gland Insufficiency by Tissue Engineering and Cell Therapy. Part 1: Regeneration of Lacrimal Gland Tissue: Can We Stimulate Lacrimal Gland Renewal In Vivo? |
| Q90153796 | Development of lacrimal gland inflammation in the mouse model of herpes stromal keratitis |
| Q64244837 | Effect of topical 0.05% cyclosporine A on the tear protein lacritin in a rat model of dry eye |
| Q28119133 | Lacritin Salvages Human Corneal Epithelial Cells from Lipopolysaccharide Induced Cell Death |
| Q30278788 | Lacritin and other autophagy associated proteins in ocular surface health |
| Q34542159 | Reduced Levels of Tear Lacritin Are Associated With Corneal Neuropathy in Patients With the Ocular Component of Sjögren's Syndrome |
| Q38652990 | TFOS DEWS II Tear Film Report. |
| Q50039889 | [Novel current and future therapy options for treatment of dry eye disease]. |
Search more.